Triptorelin Pamoate

双羟萘酸曲普瑞林

Report date: 2025/08/25 17:46:57
NME

Base Information

Drug NameTriptorelin Pamoate
Drug Alias NameTriptorelinumTriptorelinaTriptorelin EmbonateSalvacylPamorelin LA (pamoate salt) +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsPuberty, PrecociousInfertility, FemaleEndometriosis +[6] 
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaProstatic Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date2000/06/15
Country/TerritoryBelgiumBulgariaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesActavis A/S
China Registration ClassN/A

Develop Information

Active CompaniesIpsenBeaufour-Ipsen (Tianjin) Pharmaceutical Co LtdDexa Medica +[10] 
Inactive CompaniesUniversitair Ziekenhuis BrusselInstituto De Investigacion Sanitaria La FeDebiopharm International Sa
Active IndicationsPuberty, PrecociousProstatic Neoplasms
Inactive IndicationsInfertility, FemaleEndometriosisFemale Urogenital Diseases +[4] 

Other Information

ATC CodeL02AE04
Related LinksWikipediaDrugBankKEGG